Litigation Details for IMPAX LABORATORIES, INC. v. ACTAVIS LABORATORIES FL, INC. (D.N.J. 2015)
✉ Email this page to a colleague
IMPAX LABORATORIES, INC. v. ACTAVIS LABORATORIES FL, INC. (D.N.J. 2015)
| Docket | ⤷ Try a Trial | Date Filed | 2015-09-17 |
| Court | District Court, D. New Jersey | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | Stanley R. Chesler |
| Jury Demand | None | Referred To | Cathy L. Waldor |
| Patents | 7,659,254; 8,557,283; 9,089,608; 9,463,246; 9,533,046 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in IMPAX LABORATORIES, INC. v. ACTAVIS LABORATORIES FL, INC.
The small molecule drugs covered by the patents cited in this case are ⤷ Try a Trial and ⤷ Try a Trial .
Details for IMPAX LABORATORIES, INC. v. ACTAVIS LABORATORIES FL, INC. (D.N.J. 2015)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2018-04-18 | 192 | with intake of food by said subject. U.S. Patent No. 7,659,254. In Shire, the proposed label stated that… claims in U.S. Patent Nos. 8,557,283 (“the ’283 patent”), 9,089,608 (“the ’608 patent”), 9,463,246 (“…(“the ’246 patent”), and 9,533,046 (“the ’046 patent”):1 Patent Claims …intrinsic to the patent (the patent claims and specifications, along with the patent’s prosecution history…expiration of the relevant patents. This consolidated case now involves four patents. Actavis moves for summary | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
